SlideShare a Scribd company logo
1 of 3
Confidential and Proprietary, © 2013 United HealthCare Services, Inc.
1
UnitedHealthcare Pharmacy
Clinical Pharmacy Programs
Program Notification - Standard
Medication Truvada®
(emtricitabine/tenofovir disoproxil fumarate)
Date Approved 11/2012
Date Revised 04/2013
1. Background:
Truvada®
(emtricitabine/tenofovir disoproxil fumarate) is a combination of Emtriva®
(emtricitabine) and Viread®
(tenofovir disoproxil fumarate), both nucleoside analog HIV-1
reverse transcriptase inhibitors. Truvada is indicated in combination with other antiretroviral
agents for the treatment of HIV-1 infection in adults and pediatric patients 12 years of age and
older. Truvada is indicated in combination with safer sex practices for pre-exposure prophylaxis
(PrEP) to reduce the risk of sexually acquired HIV-1 in adults at high risk.
Prior to initiating Truvada for PrEP: if clinical symptoms consistent with acute viral infection are
present and recent (<1 month) exposures are suspected, delay starting PrEP for at least one
month and reconfirm negative HIV-1 status or use a test approved by the FDA as an aid in the
diagnosis of HIV-1 infection, including acute or primary HIV-1 infection. While using Truvada
for PrEP -HIV-1 screening tests should be repeated at least every 3 months.
The use of Truvada as a 2-drug post exposure antiretroviral regimen for the prevention of HIV
infection after either an occupational or non-occupational exposure to the HIV virus is supported
by guidelines from both the Centers for Disease Control and the World Health Organization2,3
.
Members who are on combination therapy with another antiretroviral medication for the
treatment of HIV infection as documented in the claims history will be allowed to continue to
receive coverage for their current therapy. Members who are on Truvada as monotherapy will be
required to meet the coverage criteria below.
2. Coverage Criteria:
A. HIV Infection
1. Truvada will be approved based on the following criterion:
a. Patient has a confirmed diagnosis of HIV infection
Authorization will be issued for 60 months.
B. Post exposure prophylaxis (PEP) to reduce the risk of HIV infection from
either an occupational or non-occupational known or suspected possible
exposure to the HIV virus
1. Truvada will be approved based on both of the following criteria:
Confidential and Proprietary, © 2013 United HealthCare Services, Inc.
2
a. Patient experienced a known or suspected possible exposure to the HIV
virus
-AND-
b. One of the following:
(1) therapy was initiated within 72 hours of exposure
(2) therapy will be initiated within 72 hours of exposure
Authorization will be issued for 1 month
C. Pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1
infection in adults at high risk
1. Initial Therapy
a. Truvada will be approved based on all of the following criteria:
(1) Patient has been determined to be at high risk for HIV-1 infection
-AND-
(2) Patient has received counseling on safe sex practices and HIV infection
risk reduction.
-AND-
(3) Patient has no clinical symptoms consistent with acute viral infection
-AND-
(4) No recent (< 1 month) HIV exposures are suspected
-AND-
(5) Patient has a confirmed negative HIV-1 status within the past week
Authorization will be issued for 6 months.
2. Reauthorization
a. Truvada will be approved based on the following criteria:
(1) Patient has been determined to be at high risk for HIV-1 infection despite
Confidential and Proprietary, © 2013 United HealthCare Services, Inc.
3
prior counseling on safe sex practices and HIV infection risk reduction.
-AND-
(2) Patient continues to receive counseling on safe sex practices and HIV
infection risk reduction.
-AND-
(3) Patient has no clinical symptoms consistent with acute viral infection
-AND-
(4) No recent (< 1 month) HIV exposures are suspected
-AND-
(5) Patient has a confirmed negative HIV-1 status within the past 3 months.
Authorization will be issued for 6 months.
3. Additional Clinical Rules: None
4. References:
1. Truvada® [Package Insert]. Foster City, CA: Gilead Sciences, Inc; July 2012.
2. Centers for Disease Control and Prevention. Updated U.S. Public Health Service
guidelines for the management of occupational exposures to HIV and
recommendations for Postexposure Prophylaxis. MMWR 2005;54(No. RR-9):
[inclusive page numbers].
3. Post-exposure prophylaxis to prevent HIV infection: joint WHO/ILO guidelines on
post-exposure prophylaxis (PEP) to prevent HIV infection. Accessed February 26,
2013 from http://www.who.int/hiv/pub/guidelines/PEP/en/

More Related Content

What's hot

Dr hatem el bitar covid19 presention for pediatric
Dr hatem el bitar covid19 presention for pediatricDr hatem el bitar covid19 presention for pediatric
Dr hatem el bitar covid19 presention for pediatricد حاتم البيطار
 
Covid 19 vaccination [autosaved]
Covid 19 vaccination [autosaved]Covid 19 vaccination [autosaved]
Covid 19 vaccination [autosaved]Bhushan Kamble
 
PEP(Post-Exposure Prophylaxis)
PEP(Post-Exposure Prophylaxis)PEP(Post-Exposure Prophylaxis)
PEP(Post-Exposure Prophylaxis)VisualBee.com
 
Acip clinical considerations
Acip clinical considerationsAcip clinical considerations
Acip clinical considerationsBassem Matta
 
Hawaii - Vector Control - Who's Who - What's What - Responsible Citizenship
Hawaii - Vector Control - Who's Who - What's What - Responsible CitizenshipHawaii - Vector Control - Who's Who - What's What - Responsible Citizenship
Hawaii - Vector Control - Who's Who - What's What - Responsible CitizenshipClifton M. Hasegawa & Associates, LLC
 
COVID-19 Vaccination Strategies for Youth
COVID-19 Vaccination Strategies for YouthCOVID-19 Vaccination Strategies for Youth
COVID-19 Vaccination Strategies for YouthCHC Connecticut
 
Consolidated guidelines
Consolidated guidelinesConsolidated guidelines
Consolidated guidelinesclac.cab
 
Corona vaccine for cancer patients
Corona vaccine for cancer patientsCorona vaccine for cancer patients
Corona vaccine for cancer patientsKanhu Charan
 
Financial Aspects of Genetic Testing - 1/11/22
Financial Aspects of Genetic Testing - 1/11/22Financial Aspects of Genetic Testing - 1/11/22
Financial Aspects of Genetic Testing - 1/11/22CHC Connecticut
 
Restart fertility in Covid19: Indian Perspective and International Guidance
Restart fertility in Covid19: Indian Perspective and International GuidanceRestart fertility in Covid19: Indian Perspective and International Guidance
Restart fertility in Covid19: Indian Perspective and International GuidanceShivani Sachdev
 
www.medicotesting.com , AIDS ppt
www.medicotesting.com , AIDS pptwww.medicotesting.com , AIDS ppt
www.medicotesting.com , AIDS pptSmruti Patanaik
 
Perception and Behavioural Outcome towards COVID-19 Vaccine among Students an...
Perception and Behavioural Outcome towards COVID-19 Vaccine among Students an...Perception and Behavioural Outcome towards COVID-19 Vaccine among Students an...
Perception and Behavioural Outcome towards COVID-19 Vaccine among Students an...Kailash Nagar
 
Evolving Switch Strategies for Virologically Suppressed HIV-Infected Patients...
Evolving Switch Strategies for Virologically Suppressed HIV-Infected Patients...Evolving Switch Strategies for Virologically Suppressed HIV-Infected Patients...
Evolving Switch Strategies for Virologically Suppressed HIV-Infected Patients...Hivlife Info
 
COVID-19 FQHC’s Emergency Preparedness Planning
COVID-19 FQHC’s Emergency Preparedness PlanningCOVID-19 FQHC’s Emergency Preparedness Planning
COVID-19 FQHC’s Emergency Preparedness PlanningCHC Connecticut
 
Weitzman ECHO COVID-19: Caring for Key Populations
Weitzman ECHO COVID-19: Caring for Key PopulationsWeitzman ECHO COVID-19: Caring for Key Populations
Weitzman ECHO COVID-19: Caring for Key PopulationsCHC Connecticut
 
Weitzman ECHO: COVID-19 in Primary Care
Weitzman ECHO: COVID-19 in Primary CareWeitzman ECHO: COVID-19 in Primary Care
Weitzman ECHO: COVID-19 in Primary CareCHC Connecticut
 
Covid 19 vaccine conversations 2021 01-20
Covid 19 vaccine conversations 2021 01-20Covid 19 vaccine conversations 2021 01-20
Covid 19 vaccine conversations 2021 01-20CHC Connecticut
 

What's hot (20)

Dr hatem el bitar covid19 presention for pediatric
Dr hatem el bitar covid19 presention for pediatricDr hatem el bitar covid19 presention for pediatric
Dr hatem el bitar covid19 presention for pediatric
 
Covid 19 vaccination [autosaved]
Covid 19 vaccination [autosaved]Covid 19 vaccination [autosaved]
Covid 19 vaccination [autosaved]
 
NYSDOH AI Diagnosis and Management of HIV-2 in Adults
NYSDOH AI Diagnosis and Management of HIV-2 in AdultsNYSDOH AI Diagnosis and Management of HIV-2 in Adults
NYSDOH AI Diagnosis and Management of HIV-2 in Adults
 
COVID-19
COVID-19COVID-19
COVID-19
 
PEP(Post-Exposure Prophylaxis)
PEP(Post-Exposure Prophylaxis)PEP(Post-Exposure Prophylaxis)
PEP(Post-Exposure Prophylaxis)
 
Acip clinical considerations
Acip clinical considerationsAcip clinical considerations
Acip clinical considerations
 
Hawaii - Vector Control - Who's Who - What's What - Responsible Citizenship
Hawaii - Vector Control - Who's Who - What's What - Responsible CitizenshipHawaii - Vector Control - Who's Who - What's What - Responsible Citizenship
Hawaii - Vector Control - Who's Who - What's What - Responsible Citizenship
 
Possible Neurological Complications following COVID-19 Vaccines
Possible Neurological Complications following COVID-19 VaccinesPossible Neurological Complications following COVID-19 Vaccines
Possible Neurological Complications following COVID-19 Vaccines
 
COVID-19 Vaccination Strategies for Youth
COVID-19 Vaccination Strategies for YouthCOVID-19 Vaccination Strategies for Youth
COVID-19 Vaccination Strategies for Youth
 
Consolidated guidelines
Consolidated guidelinesConsolidated guidelines
Consolidated guidelines
 
Corona vaccine for cancer patients
Corona vaccine for cancer patientsCorona vaccine for cancer patients
Corona vaccine for cancer patients
 
Financial Aspects of Genetic Testing - 1/11/22
Financial Aspects of Genetic Testing - 1/11/22Financial Aspects of Genetic Testing - 1/11/22
Financial Aspects of Genetic Testing - 1/11/22
 
Restart fertility in Covid19: Indian Perspective and International Guidance
Restart fertility in Covid19: Indian Perspective and International GuidanceRestart fertility in Covid19: Indian Perspective and International Guidance
Restart fertility in Covid19: Indian Perspective and International Guidance
 
www.medicotesting.com , AIDS ppt
www.medicotesting.com , AIDS pptwww.medicotesting.com , AIDS ppt
www.medicotesting.com , AIDS ppt
 
Perception and Behavioural Outcome towards COVID-19 Vaccine among Students an...
Perception and Behavioural Outcome towards COVID-19 Vaccine among Students an...Perception and Behavioural Outcome towards COVID-19 Vaccine among Students an...
Perception and Behavioural Outcome towards COVID-19 Vaccine among Students an...
 
Evolving Switch Strategies for Virologically Suppressed HIV-Infected Patients...
Evolving Switch Strategies for Virologically Suppressed HIV-Infected Patients...Evolving Switch Strategies for Virologically Suppressed HIV-Infected Patients...
Evolving Switch Strategies for Virologically Suppressed HIV-Infected Patients...
 
COVID-19 FQHC’s Emergency Preparedness Planning
COVID-19 FQHC’s Emergency Preparedness PlanningCOVID-19 FQHC’s Emergency Preparedness Planning
COVID-19 FQHC’s Emergency Preparedness Planning
 
Weitzman ECHO COVID-19: Caring for Key Populations
Weitzman ECHO COVID-19: Caring for Key PopulationsWeitzman ECHO COVID-19: Caring for Key Populations
Weitzman ECHO COVID-19: Caring for Key Populations
 
Weitzman ECHO: COVID-19 in Primary Care
Weitzman ECHO: COVID-19 in Primary CareWeitzman ECHO: COVID-19 in Primary Care
Weitzman ECHO: COVID-19 in Primary Care
 
Covid 19 vaccine conversations 2021 01-20
Covid 19 vaccine conversations 2021 01-20Covid 19 vaccine conversations 2021 01-20
Covid 19 vaccine conversations 2021 01-20
 

Similar to UnitedHealthcare Criteria for Truvada Coverage

ANTI RETRO VIRAL THERAPY- WHO & NACO - ROLE OF STAFF NURSES IN ART CENTRE
ANTI RETRO VIRAL THERAPY- WHO & NACO - ROLE OF STAFF NURSES IN ART CENTRE ANTI RETRO VIRAL THERAPY- WHO & NACO - ROLE OF STAFF NURSES IN ART CENTRE
ANTI RETRO VIRAL THERAPY- WHO & NACO - ROLE OF STAFF NURSES IN ART CENTRE prabuganesan3
 
Post Exposure Prophylaxis by Dr Dele
Post Exposure Prophylaxis by Dr DelePost Exposure Prophylaxis by Dr Dele
Post Exposure Prophylaxis by Dr DeleKemi Dele-Ijagbulu
 
Conception and Antiretroviral Therapy
Conception and Antiretroviral TherapyConception and Antiretroviral Therapy
Conception and Antiretroviral TherapyPravin Prasad
 
Cовременное лечение ВИЧ : новые данные с конференции CROI 2017/ Contemporary...
Cовременное лечение ВИЧ : новые данные с  конференции CROI 2017/ Contemporary...Cовременное лечение ВИЧ : новые данные с  конференции CROI 2017/ Contemporary...
Cовременное лечение ВИЧ : новые данные с конференции CROI 2017/ Contemporary...hivlifeinfo
 
03.02 management of patients on antiretroviral drugs initiat
03.02 management of patients on antiretroviral drugs initiat03.02 management of patients on antiretroviral drugs initiat
03.02 management of patients on antiretroviral drugs initiatDavid Ngogoyo
 
Случаи и разногласия по ВИЧ в 2019 году: европейские перспективы / Cases and...
 Случаи и разногласия по ВИЧ в 2019 году: европейские перспективы / Cases and... Случаи и разногласия по ВИЧ в 2019 году: европейские перспективы / Cases and...
Случаи и разногласия по ВИЧ в 2019 году: европейские перспективы / Cases and...hivlifeinfo
 
Key Facts over HIV by Dr. Milind Kulkarni
Key Facts over HIV by Dr. Milind KulkarniKey Facts over HIV by Dr. Milind Kulkarni
Key Facts over HIV by Dr. Milind KulkarniParvez Pathan
 
02.02 adult art initiation gsn
02.02 adult  art initiation gsn02.02 adult  art initiation gsn
02.02 adult art initiation gsnDavid Ngogoyo
 
Aidsrounds121412morris 121214115641-phpapp01
Aidsrounds121412morris 121214115641-phpapp01Aidsrounds121412morris 121214115641-phpapp01
Aidsrounds121412morris 121214115641-phpapp01Lucas Brown
 
0. 2016 WHO ART Guidelines_General Overview.pptx
0. 2016 WHO ART Guidelines_General Overview.pptx0. 2016 WHO ART Guidelines_General Overview.pptx
0. 2016 WHO ART Guidelines_General Overview.pptxyakemichael
 
Современное лечение ВИЧ : АРТ как профилактика.Contemporary Management of HIV...
Современное лечение ВИЧ : АРТ как профилактика.Contemporary Management of HIV...Современное лечение ВИЧ : АРТ как профилактика.Contemporary Management of HIV...
Современное лечение ВИЧ : АРТ как профилактика.Contemporary Management of HIV...hivlifeinfo
 
Presentation ipre xwebsite
Presentation ipre xwebsitePresentation ipre xwebsite
Presentation ipre xwebsiteJames Wilton
 

Similar to UnitedHealthcare Criteria for Truvada Coverage (20)

The HIV Prevention–Certified Provider Program: A Training and Certificate Pro...
The HIV Prevention–Certified Provider Program: A Training and Certificate Pro...The HIV Prevention–Certified Provider Program: A Training and Certificate Pro...
The HIV Prevention–Certified Provider Program: A Training and Certificate Pro...
 
11915935.ppt
11915935.ppt11915935.ppt
11915935.ppt
 
ANTI RETRO VIRAL THERAPY- WHO & NACO - ROLE OF STAFF NURSES IN ART CENTRE
ANTI RETRO VIRAL THERAPY- WHO & NACO - ROLE OF STAFF NURSES IN ART CENTRE ANTI RETRO VIRAL THERAPY- WHO & NACO - ROLE OF STAFF NURSES IN ART CENTRE
ANTI RETRO VIRAL THERAPY- WHO & NACO - ROLE OF STAFF NURSES IN ART CENTRE
 
PrEP: Research update and implementation program in NSW
PrEP: Research update and implementation program in NSWPrEP: Research update and implementation program in NSW
PrEP: Research update and implementation program in NSW
 
Post Exposure Prophylaxis by Dr Dele
Post Exposure Prophylaxis by Dr DelePost Exposure Prophylaxis by Dr Dele
Post Exposure Prophylaxis by Dr Dele
 
Conception and Antiretroviral Therapy
Conception and Antiretroviral TherapyConception and Antiretroviral Therapy
Conception and Antiretroviral Therapy
 
HIV Treatment and PrEP in 2015
HIV Treatment and PrEP in 2015HIV Treatment and PrEP in 2015
HIV Treatment and PrEP in 2015
 
Cовременное лечение ВИЧ : новые данные с конференции CROI 2017/ Contemporary...
Cовременное лечение ВИЧ : новые данные с  конференции CROI 2017/ Contemporary...Cовременное лечение ВИЧ : новые данные с  конференции CROI 2017/ Contemporary...
Cовременное лечение ВИЧ : новые данные с конференции CROI 2017/ Contemporary...
 
Pv overview (2)
Pv overview (2)Pv overview (2)
Pv overview (2)
 
03.02 management of patients on antiretroviral drugs initiat
03.02 management of patients on antiretroviral drugs initiat03.02 management of patients on antiretroviral drugs initiat
03.02 management of patients on antiretroviral drugs initiat
 
Случаи и разногласия по ВИЧ в 2019 году: европейские перспективы / Cases and...
 Случаи и разногласия по ВИЧ в 2019 году: европейские перспективы / Cases and... Случаи и разногласия по ВИЧ в 2019 году: европейские перспективы / Cases and...
Случаи и разногласия по ВИЧ в 2019 году: европейские перспективы / Cases and...
 
Key Facts over HIV by Dr. Milind Kulkarni
Key Facts over HIV by Dr. Milind KulkarniKey Facts over HIV by Dr. Milind Kulkarni
Key Facts over HIV by Dr. Milind Kulkarni
 
Adult schedule-11x17
Adult schedule-11x17Adult schedule-11x17
Adult schedule-11x17
 
MyPrEPPlan
MyPrEPPlanMyPrEPPlan
MyPrEPPlan
 
P4065
P4065P4065
P4065
 
02.02 adult art initiation gsn
02.02 adult  art initiation gsn02.02 adult  art initiation gsn
02.02 adult art initiation gsn
 
Aidsrounds121412morris 121214115641-phpapp01
Aidsrounds121412morris 121214115641-phpapp01Aidsrounds121412morris 121214115641-phpapp01
Aidsrounds121412morris 121214115641-phpapp01
 
0. 2016 WHO ART Guidelines_General Overview.pptx
0. 2016 WHO ART Guidelines_General Overview.pptx0. 2016 WHO ART Guidelines_General Overview.pptx
0. 2016 WHO ART Guidelines_General Overview.pptx
 
Современное лечение ВИЧ : АРТ как профилактика.Contemporary Management of HIV...
Современное лечение ВИЧ : АРТ как профилактика.Contemporary Management of HIV...Современное лечение ВИЧ : АРТ как профилактика.Contemporary Management of HIV...
Современное лечение ВИЧ : АРТ как профилактика.Contemporary Management of HIV...
 
Presentation ipre xwebsite
Presentation ipre xwebsitePresentation ipre xwebsite
Presentation ipre xwebsite
 

More from Jim Pickett

Project RSP Training on PrEP - November 13, 2015
Project RSP Training on PrEP - November 13, 2015Project RSP Training on PrEP - November 13, 2015
Project RSP Training on PrEP - November 13, 2015Jim Pickett
 
Project RSP Training on PrEP - September 11, 2015
Project RSP Training on PrEP - September 11, 2015Project RSP Training on PrEP - September 11, 2015
Project RSP Training on PrEP - September 11, 2015Jim Pickett
 
Project RSP! Training on PrEP - Peoria, IL - August 18, 2015
Project RSP! Training on PrEP - Peoria, IL - August 18, 2015Project RSP! Training on PrEP - Peoria, IL - August 18, 2015
Project RSP! Training on PrEP - Peoria, IL - August 18, 2015Jim Pickett
 
Project RSP Training on PrEP - July 31, 2015
Project RSP Training on PrEP - July 31, 2015Project RSP Training on PrEP - July 31, 2015
Project RSP Training on PrEP - July 31, 2015Jim Pickett
 
PrEP Training Slides - Austin CBC, CORE Center, AFC
PrEP Training Slides - Austin CBC, CORE Center, AFCPrEP Training Slides - Austin CBC, CORE Center, AFC
PrEP Training Slides - Austin CBC, CORE Center, AFCJim Pickett
 
PrEP Training Slides - IDPH/MATEC/AFC training in Collinsville, June 3, '15
PrEP Training Slides - IDPH/MATEC/AFC training in Collinsville, June 3, '15PrEP Training Slides - IDPH/MATEC/AFC training in Collinsville, June 3, '15
PrEP Training Slides - IDPH/MATEC/AFC training in Collinsville, June 3, '15Jim Pickett
 
PrEP Training - Springfield, IL - May 14, 2015
PrEP Training - Springfield, IL - May 14, 2015PrEP Training - Springfield, IL - May 14, 2015
PrEP Training - Springfield, IL - May 14, 2015Jim Pickett
 
PrEP training slides - Lisle, April 16, 2015
PrEP training slides - Lisle, April 16, 2015PrEP training slides - Lisle, April 16, 2015
PrEP training slides - Lisle, April 16, 2015Jim Pickett
 
Project RSP! training on PrEP for the HIV workforce (March 19, 2015)
Project RSP! training on PrEP for the HIV workforce (March 19, 2015)Project RSP! training on PrEP for the HIV workforce (March 19, 2015)
Project RSP! training on PrEP for the HIV workforce (March 19, 2015)Jim Pickett
 
The Rectal Revolution is Here - January 29, 2015 - New Orleans, LA
The Rectal Revolution is Here - January 29, 2015 - New Orleans, LAThe Rectal Revolution is Here - January 29, 2015 - New Orleans, LA
The Rectal Revolution is Here - January 29, 2015 - New Orleans, LAJim Pickett
 
Dec 11, '14 WEBINAR - Lubes, Rings, Films, Fibers, and Shots 4 HIV Prevention
Dec 11, '14 WEBINAR - Lubes, Rings, Films, Fibers, and Shots 4 HIV PreventionDec 11, '14 WEBINAR - Lubes, Rings, Films, Fibers, and Shots 4 HIV Prevention
Dec 11, '14 WEBINAR - Lubes, Rings, Films, Fibers, and Shots 4 HIV PreventionJim Pickett
 
Project Ready, Set, PrEP! training on PrEP for HIV Prevention - UPDATED NOV 17
Project Ready, Set, PrEP! training on PrEP for HIV Prevention - UPDATED NOV 17Project Ready, Set, PrEP! training on PrEP for HIV Prevention - UPDATED NOV 17
Project Ready, Set, PrEP! training on PrEP for HIV Prevention - UPDATED NOV 17Jim Pickett
 
Exploring the Pipeline: Lubes, Rings, Films, Fibers, and Shots 4 HIV Prevention
Exploring the Pipeline: Lubes, Rings, Films, Fibers, and Shots 4 HIV PreventionExploring the Pipeline: Lubes, Rings, Films, Fibers, and Shots 4 HIV Prevention
Exploring the Pipeline: Lubes, Rings, Films, Fibers, and Shots 4 HIV PreventionJim Pickett
 
Project RSP+ "Exploring the Pipeline"
Project RSP+ "Exploring the Pipeline"Project RSP+ "Exploring the Pipeline"
Project RSP+ "Exploring the Pipeline"Jim Pickett
 
Real, Raw, and Uncut
Real, Raw, and UncutReal, Raw, and Uncut
Real, Raw, and UncutJim Pickett
 
Beyond PrEP: Intersectionality, Resilience & the Health of Black MSM
Beyond PrEP: Intersectionality, Resilience & the Health of Black MSMBeyond PrEP: Intersectionality, Resilience & the Health of Black MSM
Beyond PrEP: Intersectionality, Resilience & the Health of Black MSMJim Pickett
 
Living is a Risk Behavior
Living is a Risk BehaviorLiving is a Risk Behavior
Living is a Risk BehaviorJim Pickett
 
New Rules About Safer Sex
New Rules About Safer SexNew Rules About Safer Sex
New Rules About Safer SexJim Pickett
 
Invisible Men who have Sex with Men and Survival: From Practice to Research a...
Invisible Men who have Sex with Men and Survival: From Practice to Research a...Invisible Men who have Sex with Men and Survival: From Practice to Research a...
Invisible Men who have Sex with Men and Survival: From Practice to Research a...Jim Pickett
 
Project Ready, Set, PrEP! training on PrEP - Updated 9/5/14
Project Ready, Set, PrEP! training on PrEP - Updated 9/5/14Project Ready, Set, PrEP! training on PrEP - Updated 9/5/14
Project Ready, Set, PrEP! training on PrEP - Updated 9/5/14Jim Pickett
 

More from Jim Pickett (20)

Project RSP Training on PrEP - November 13, 2015
Project RSP Training on PrEP - November 13, 2015Project RSP Training on PrEP - November 13, 2015
Project RSP Training on PrEP - November 13, 2015
 
Project RSP Training on PrEP - September 11, 2015
Project RSP Training on PrEP - September 11, 2015Project RSP Training on PrEP - September 11, 2015
Project RSP Training on PrEP - September 11, 2015
 
Project RSP! Training on PrEP - Peoria, IL - August 18, 2015
Project RSP! Training on PrEP - Peoria, IL - August 18, 2015Project RSP! Training on PrEP - Peoria, IL - August 18, 2015
Project RSP! Training on PrEP - Peoria, IL - August 18, 2015
 
Project RSP Training on PrEP - July 31, 2015
Project RSP Training on PrEP - July 31, 2015Project RSP Training on PrEP - July 31, 2015
Project RSP Training on PrEP - July 31, 2015
 
PrEP Training Slides - Austin CBC, CORE Center, AFC
PrEP Training Slides - Austin CBC, CORE Center, AFCPrEP Training Slides - Austin CBC, CORE Center, AFC
PrEP Training Slides - Austin CBC, CORE Center, AFC
 
PrEP Training Slides - IDPH/MATEC/AFC training in Collinsville, June 3, '15
PrEP Training Slides - IDPH/MATEC/AFC training in Collinsville, June 3, '15PrEP Training Slides - IDPH/MATEC/AFC training in Collinsville, June 3, '15
PrEP Training Slides - IDPH/MATEC/AFC training in Collinsville, June 3, '15
 
PrEP Training - Springfield, IL - May 14, 2015
PrEP Training - Springfield, IL - May 14, 2015PrEP Training - Springfield, IL - May 14, 2015
PrEP Training - Springfield, IL - May 14, 2015
 
PrEP training slides - Lisle, April 16, 2015
PrEP training slides - Lisle, April 16, 2015PrEP training slides - Lisle, April 16, 2015
PrEP training slides - Lisle, April 16, 2015
 
Project RSP! training on PrEP for the HIV workforce (March 19, 2015)
Project RSP! training on PrEP for the HIV workforce (March 19, 2015)Project RSP! training on PrEP for the HIV workforce (March 19, 2015)
Project RSP! training on PrEP for the HIV workforce (March 19, 2015)
 
The Rectal Revolution is Here - January 29, 2015 - New Orleans, LA
The Rectal Revolution is Here - January 29, 2015 - New Orleans, LAThe Rectal Revolution is Here - January 29, 2015 - New Orleans, LA
The Rectal Revolution is Here - January 29, 2015 - New Orleans, LA
 
Dec 11, '14 WEBINAR - Lubes, Rings, Films, Fibers, and Shots 4 HIV Prevention
Dec 11, '14 WEBINAR - Lubes, Rings, Films, Fibers, and Shots 4 HIV PreventionDec 11, '14 WEBINAR - Lubes, Rings, Films, Fibers, and Shots 4 HIV Prevention
Dec 11, '14 WEBINAR - Lubes, Rings, Films, Fibers, and Shots 4 HIV Prevention
 
Project Ready, Set, PrEP! training on PrEP for HIV Prevention - UPDATED NOV 17
Project Ready, Set, PrEP! training on PrEP for HIV Prevention - UPDATED NOV 17Project Ready, Set, PrEP! training on PrEP for HIV Prevention - UPDATED NOV 17
Project Ready, Set, PrEP! training on PrEP for HIV Prevention - UPDATED NOV 17
 
Exploring the Pipeline: Lubes, Rings, Films, Fibers, and Shots 4 HIV Prevention
Exploring the Pipeline: Lubes, Rings, Films, Fibers, and Shots 4 HIV PreventionExploring the Pipeline: Lubes, Rings, Films, Fibers, and Shots 4 HIV Prevention
Exploring the Pipeline: Lubes, Rings, Films, Fibers, and Shots 4 HIV Prevention
 
Project RSP+ "Exploring the Pipeline"
Project RSP+ "Exploring the Pipeline"Project RSP+ "Exploring the Pipeline"
Project RSP+ "Exploring the Pipeline"
 
Real, Raw, and Uncut
Real, Raw, and UncutReal, Raw, and Uncut
Real, Raw, and Uncut
 
Beyond PrEP: Intersectionality, Resilience & the Health of Black MSM
Beyond PrEP: Intersectionality, Resilience & the Health of Black MSMBeyond PrEP: Intersectionality, Resilience & the Health of Black MSM
Beyond PrEP: Intersectionality, Resilience & the Health of Black MSM
 
Living is a Risk Behavior
Living is a Risk BehaviorLiving is a Risk Behavior
Living is a Risk Behavior
 
New Rules About Safer Sex
New Rules About Safer SexNew Rules About Safer Sex
New Rules About Safer Sex
 
Invisible Men who have Sex with Men and Survival: From Practice to Research a...
Invisible Men who have Sex with Men and Survival: From Practice to Research a...Invisible Men who have Sex with Men and Survival: From Practice to Research a...
Invisible Men who have Sex with Men and Survival: From Practice to Research a...
 
Project Ready, Set, PrEP! training on PrEP - Updated 9/5/14
Project Ready, Set, PrEP! training on PrEP - Updated 9/5/14Project Ready, Set, PrEP! training on PrEP - Updated 9/5/14
Project Ready, Set, PrEP! training on PrEP - Updated 9/5/14
 

Recently uploaded

Post-Cycle Therapy (PCT) in bodybuilding docx.pdf
Post-Cycle Therapy (PCT) in bodybuilding  docx.pdfPost-Cycle Therapy (PCT) in bodybuilding  docx.pdf
Post-Cycle Therapy (PCT) in bodybuilding docx.pdfAea.ltd
 
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depthsUnveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depthsYash Garg
 
Tips to Choose the Best Psychiatrists in Indore
Tips to Choose the Best Psychiatrists in IndoreTips to Choose the Best Psychiatrists in Indore
Tips to Choose the Best Psychiatrists in IndoreGokuldas Hospital
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...Ayman Seddik
 
Treatment Choices for Slip Disc at Gokuldas Hospital
Treatment Choices for Slip Disc at Gokuldas HospitalTreatment Choices for Slip Disc at Gokuldas Hospital
Treatment Choices for Slip Disc at Gokuldas HospitalGokuldas Hospital
 
Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?bkling
 
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxIs Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxSamar Tharwat
 
Capillary Blood Collection Tubes: The Complete Guidebook
Capillary Blood Collection Tubes: The Complete GuidebookCapillary Blood Collection Tubes: The Complete Guidebook
Capillary Blood Collection Tubes: The Complete GuidebookNanchang Kindly Meditech
 
Video capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenVideo capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenRaju678948
 
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019Akash Agnihotri
 
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptxThe Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptxDr. Rabia Inam Gandapore
 
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsConnective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsMedicoseAcademics
 
DR. Neha Mehta Best Psychologist.in India
DR. Neha Mehta Best Psychologist.in IndiaDR. Neha Mehta Best Psychologist.in India
DR. Neha Mehta Best Psychologist.in IndiaNehamehta128467
 
Varicose Veins Treatment Aftercare Tips by Gokuldas Hospital
Varicose Veins Treatment Aftercare Tips by Gokuldas HospitalVaricose Veins Treatment Aftercare Tips by Gokuldas Hospital
Varicose Veins Treatment Aftercare Tips by Gokuldas HospitalGokuldas Hospital
 
How to buy 5cladba precursor raw 5cl-adb-a raw material
How to buy 5cladba precursor raw 5cl-adb-a raw materialHow to buy 5cladba precursor raw 5cl-adb-a raw material
How to buy 5cladba precursor raw 5cl-adb-a raw materialSherrylee83
 
Sonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptxSonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptxpalsonia139
 
VVIP Hadapsar ℂall Girls 6350482085 Scorching { Pune } Excellent Girl Serviℂe...
VVIP Hadapsar ℂall Girls 6350482085 Scorching { Pune } Excellent Girl Serviℂe...VVIP Hadapsar ℂall Girls 6350482085 Scorching { Pune } Excellent Girl Serviℂe...
VVIP Hadapsar ℂall Girls 6350482085 Scorching { Pune } Excellent Girl Serviℂe...dhyaansingh0898#S07
 
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptxANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptxDr. Sohan Biswas
 
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose AcademicsCytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose AcademicsMedicoseAcademics
 

Recently uploaded (20)

Post-Cycle Therapy (PCT) in bodybuilding docx.pdf
Post-Cycle Therapy (PCT) in bodybuilding  docx.pdfPost-Cycle Therapy (PCT) in bodybuilding  docx.pdf
Post-Cycle Therapy (PCT) in bodybuilding docx.pdf
 
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depthsUnveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
 
Tips to Choose the Best Psychiatrists in Indore
Tips to Choose the Best Psychiatrists in IndoreTips to Choose the Best Psychiatrists in Indore
Tips to Choose the Best Psychiatrists in Indore
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
 
Treatment Choices for Slip Disc at Gokuldas Hospital
Treatment Choices for Slip Disc at Gokuldas HospitalTreatment Choices for Slip Disc at Gokuldas Hospital
Treatment Choices for Slip Disc at Gokuldas Hospital
 
Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?
 
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxIs Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
 
Capillary Blood Collection Tubes: The Complete Guidebook
Capillary Blood Collection Tubes: The Complete GuidebookCapillary Blood Collection Tubes: The Complete Guidebook
Capillary Blood Collection Tubes: The Complete Guidebook
 
Video capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenVideo capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in children
 
In Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait City
In Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait CityIn Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait City
In Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait City
 
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
 
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptxThe Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
 
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsConnective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
 
DR. Neha Mehta Best Psychologist.in India
DR. Neha Mehta Best Psychologist.in IndiaDR. Neha Mehta Best Psychologist.in India
DR. Neha Mehta Best Psychologist.in India
 
Varicose Veins Treatment Aftercare Tips by Gokuldas Hospital
Varicose Veins Treatment Aftercare Tips by Gokuldas HospitalVaricose Veins Treatment Aftercare Tips by Gokuldas Hospital
Varicose Veins Treatment Aftercare Tips by Gokuldas Hospital
 
How to buy 5cladba precursor raw 5cl-adb-a raw material
How to buy 5cladba precursor raw 5cl-adb-a raw materialHow to buy 5cladba precursor raw 5cl-adb-a raw material
How to buy 5cladba precursor raw 5cl-adb-a raw material
 
Sonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptxSonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptx
 
VVIP Hadapsar ℂall Girls 6350482085 Scorching { Pune } Excellent Girl Serviℂe...
VVIP Hadapsar ℂall Girls 6350482085 Scorching { Pune } Excellent Girl Serviℂe...VVIP Hadapsar ℂall Girls 6350482085 Scorching { Pune } Excellent Girl Serviℂe...
VVIP Hadapsar ℂall Girls 6350482085 Scorching { Pune } Excellent Girl Serviℂe...
 
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptxANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
 
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose AcademicsCytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
 

UnitedHealthcare Criteria for Truvada Coverage

  • 1. Confidential and Proprietary, © 2013 United HealthCare Services, Inc. 1 UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Notification - Standard Medication Truvada® (emtricitabine/tenofovir disoproxil fumarate) Date Approved 11/2012 Date Revised 04/2013 1. Background: Truvada® (emtricitabine/tenofovir disoproxil fumarate) is a combination of Emtriva® (emtricitabine) and Viread® (tenofovir disoproxil fumarate), both nucleoside analog HIV-1 reverse transcriptase inhibitors. Truvada is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients 12 years of age and older. Truvada is indicated in combination with safer sex practices for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in adults at high risk. Prior to initiating Truvada for PrEP: if clinical symptoms consistent with acute viral infection are present and recent (<1 month) exposures are suspected, delay starting PrEP for at least one month and reconfirm negative HIV-1 status or use a test approved by the FDA as an aid in the diagnosis of HIV-1 infection, including acute or primary HIV-1 infection. While using Truvada for PrEP -HIV-1 screening tests should be repeated at least every 3 months. The use of Truvada as a 2-drug post exposure antiretroviral regimen for the prevention of HIV infection after either an occupational or non-occupational exposure to the HIV virus is supported by guidelines from both the Centers for Disease Control and the World Health Organization2,3 . Members who are on combination therapy with another antiretroviral medication for the treatment of HIV infection as documented in the claims history will be allowed to continue to receive coverage for their current therapy. Members who are on Truvada as monotherapy will be required to meet the coverage criteria below. 2. Coverage Criteria: A. HIV Infection 1. Truvada will be approved based on the following criterion: a. Patient has a confirmed diagnosis of HIV infection Authorization will be issued for 60 months. B. Post exposure prophylaxis (PEP) to reduce the risk of HIV infection from either an occupational or non-occupational known or suspected possible exposure to the HIV virus 1. Truvada will be approved based on both of the following criteria:
  • 2. Confidential and Proprietary, © 2013 United HealthCare Services, Inc. 2 a. Patient experienced a known or suspected possible exposure to the HIV virus -AND- b. One of the following: (1) therapy was initiated within 72 hours of exposure (2) therapy will be initiated within 72 hours of exposure Authorization will be issued for 1 month C. Pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in adults at high risk 1. Initial Therapy a. Truvada will be approved based on all of the following criteria: (1) Patient has been determined to be at high risk for HIV-1 infection -AND- (2) Patient has received counseling on safe sex practices and HIV infection risk reduction. -AND- (3) Patient has no clinical symptoms consistent with acute viral infection -AND- (4) No recent (< 1 month) HIV exposures are suspected -AND- (5) Patient has a confirmed negative HIV-1 status within the past week Authorization will be issued for 6 months. 2. Reauthorization a. Truvada will be approved based on the following criteria: (1) Patient has been determined to be at high risk for HIV-1 infection despite
  • 3. Confidential and Proprietary, © 2013 United HealthCare Services, Inc. 3 prior counseling on safe sex practices and HIV infection risk reduction. -AND- (2) Patient continues to receive counseling on safe sex practices and HIV infection risk reduction. -AND- (3) Patient has no clinical symptoms consistent with acute viral infection -AND- (4) No recent (< 1 month) HIV exposures are suspected -AND- (5) Patient has a confirmed negative HIV-1 status within the past 3 months. Authorization will be issued for 6 months. 3. Additional Clinical Rules: None 4. References: 1. Truvada® [Package Insert]. Foster City, CA: Gilead Sciences, Inc; July 2012. 2. Centers for Disease Control and Prevention. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for Postexposure Prophylaxis. MMWR 2005;54(No. RR-9): [inclusive page numbers]. 3. Post-exposure prophylaxis to prevent HIV infection: joint WHO/ILO guidelines on post-exposure prophylaxis (PEP) to prevent HIV infection. Accessed February 26, 2013 from http://www.who.int/hiv/pub/guidelines/PEP/en/